Global Biotechnology Contract Manufacturing Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI07244167

Publication Date:

July 10, 2024

Pages:

116

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The increasing popularity of biologics in medicine has led to a significant rise in outsourcing manufacturing. Biologics contract manufacturers have the know-how and setup to make these complex therapies effective while ensuring the meeting of strict quality rules and regulations.
The global Biotechnology Contract Manufacturing market size is projected to grow from US$ 17390 million in 2024 to US$ 29390 million in 2030; it is expected to grow at a CAGR of 9.1% from 2024 to 2030.
The 鈥淏iotechnology Contract Manufacturing Industry Forecast鈥� looks at past sales and reviews total world Biotechnology Contract Manufacturing sales in 2022, providing a comprehensive analysis by region and market sector of projected Biotechnology Contract Manufacturing sales for 2023 through 2029. With Biotechnology Contract Manufacturing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biotechnology Contract Manufacturing industry.
This Insight Report provides a comprehensive analysis of the global Biotechnology Contract Manufacturing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biotechnology Contract Manufacturing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Biotechnology Contract Manufacturing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biotechnology Contract Manufacturing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biotechnology Contract Manufacturing.
According to Statista, there were more than 21,000 drugs in the global R&D pipeline in 2023. Also, the FDA approved 71 new drugs in 2023; out of these, 48% of new approvals were biologics. Moreover, the demand for biologic drug substance contract manufacturing is expected to be the highest among smaller biotech companies that hold intellectual property rights for novel biologics. This has led to the incorporation of cutting-edge production methods like continuous manufacturing and single-use technologies aimed at enhancing operational efficiency and adaptability. Additionally, partnerships and collaborations between pharmaceutical firms and contract manufacturing organizations are increasing for biologic drug product manufacturing, allowing for the modification of manufacturing processes and cost-effective solutions.
This report presents a comprehensive overview, market shares, and growth opportunities of Biotechnology Contract Manufacturing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Biologic Drug Substance Manufacturing
Biologic Drug Product Manufacturing
Segmentation by Application:
Monoclonal Antibodies
Cell Therapy & Gene Therapy
Antibody-Drug Conjugates (ADCs)
Vaccines
Therapeutic Peptides & Proteins
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Biologic Drug Substance Manufacturing
Biologic Drug Product Manufacturing
Segmentation by Application:
Monoclonal Antibodies
Cell Therapy & Gene Therapy
Antibody-Drug Conjugates (ADCs)
Vaccines
Therapeutic Peptides & Proteins
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Lonza
Thermo Fisher Scientific, Inc.
Catalent, Inc.
Samsung Biologics
WuXi Biologics
Boehringer Ingelheim International GmbH
FUJIFILM Holding Corporation
AbbVie, Inc.
Eurofins Scientific
AGC, Inc.
Merck KgaA

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biotechnology Contract Manufacturing Market Size 2019-2030
2.1.2 Biotechnology Contract Manufacturing Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Biotechnology Contract Manufacturing by Country/Region, 2019, 2023 & 2030
2.2 Biotechnology Contract Manufacturing Segment by Type
2.2.1 Biologic Drug Substance Manufacturing
2.2.2 Biologic Drug Product Manufacturing
2.3 Biotechnology Contract Manufacturing Market Size by Type
2.3.1 Biotechnology Contract Manufacturing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Biotechnology Contract Manufacturing Market Size Market Share by Type (2019-2024)
2.4 Biotechnology Contract Manufacturing Segment by Application
2.4.1 Monoclonal Antibodies
2.4.2 Cell Therapy & Gene Therapy
2.4.3 Antibody-Drug Conjugates (ADCs)
2.4.4 Vaccines
2.4.5 Therapeutic Peptides & Proteins
2.4.6 Others
2.5 Biotechnology Contract Manufacturing Market Size by Application
2.5.1 Biotechnology Contract Manufacturing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Biotechnology Contract Manufacturing Market Size Market Share by Application (2019-2024)
3 Biotechnology Contract Manufacturing Market Size by Player
3.1 Biotechnology Contract Manufacturing Market Size Market Share by Player
3.1.1 Global Biotechnology Contract Manufacturing Revenue by Player (2019-2024)
3.1.2 Global Biotechnology Contract Manufacturing Revenue Market Share by Player (2019-2024)
3.2 Global Biotechnology Contract Manufacturing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Biotechnology Contract Manufacturing by Region
4.1 Biotechnology Contract Manufacturing Market Size by Region (2019-2024)
4.2 Global Biotechnology Contract Manufacturing Annual Revenue by Country/Region (2019-2024)
4.3 Americas Biotechnology Contract Manufacturing Market Size Growth (2019-2024)
4.4 APAC Biotechnology Contract Manufacturing Market Size Growth (2019-2024)
4.5 Europe Biotechnology Contract Manufacturing Market Size Growth (2019-2024)
4.6 Middle East & Africa Biotechnology Contract Manufacturing Market Size Growth (2019-2024)
5 Americas
5.1 Americas Biotechnology Contract Manufacturing Market Size by Country (2019-2024)
5.2 Americas Biotechnology Contract Manufacturing Market Size by Type (2019-2024)
5.3 Americas Biotechnology Contract Manufacturing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biotechnology Contract Manufacturing Market Size by Region (2019-2024)
6.2 APAC Biotechnology Contract Manufacturing Market Size by Type (2019-2024)
6.3 APAC Biotechnology Contract Manufacturing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Biotechnology Contract Manufacturing Market Size by Country (2019-2024)
7.2 Europe Biotechnology Contract Manufacturing Market Size by Type (2019-2024)
7.3 Europe Biotechnology Contract Manufacturing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biotechnology Contract Manufacturing by Region (2019-2024)
8.2 Middle East & Africa Biotechnology Contract Manufacturing Market Size by Type (2019-2024)
8.3 Middle East & Africa Biotechnology Contract Manufacturing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Biotechnology Contract Manufacturing Market Forecast
10.1 Global Biotechnology Contract Manufacturing Forecast by Region (2025-2030)
10.1.1 Global Biotechnology Contract Manufacturing Forecast by Region (2025-2030)
10.1.2 Americas Biotechnology Contract Manufacturing Forecast
10.1.3 APAC Biotechnology Contract Manufacturing Forecast
10.1.4 Europe Biotechnology Contract Manufacturing Forecast
10.1.5 Middle East & Africa Biotechnology Contract Manufacturing Forecast
10.2 Americas Biotechnology Contract Manufacturing Forecast by Country (2025-2030)
10.2.1 United States Market Biotechnology Contract Manufacturing Forecast
10.2.2 Canada Market Biotechnology Contract Manufacturing Forecast
10.2.3 Mexico Market Biotechnology Contract Manufacturing Forecast
10.2.4 Brazil Market Biotechnology Contract Manufacturing Forecast
10.3 APAC Biotechnology Contract Manufacturing Forecast by Region (2025-2030)
10.3.1 China Biotechnology Contract Manufacturing Market Forecast
10.3.2 Japan Market Biotechnology Contract Manufacturing Forecast
10.3.3 Korea Market Biotechnology Contract Manufacturing Forecast
10.3.4 Southeast Asia Market Biotechnology Contract Manufacturing Forecast
10.3.5 India Market Biotechnology Contract Manufacturing Forecast
10.3.6 Australia Market Biotechnology Contract Manufacturing Forecast
10.4 Europe Biotechnology Contract Manufacturing Forecast by Country (2025-2030)
10.4.1 Germany Market Biotechnology Contract Manufacturing Forecast
10.4.2 France Market Biotechnology Contract Manufacturing Forecast
10.4.3 UK Market Biotechnology Contract Manufacturing Forecast
10.4.4 Italy Market Biotechnology Contract Manufacturing Forecast
10.4.5 Russia Market Biotechnology Contract Manufacturing Forecast
10.5 Middle East & Africa Biotechnology Contract Manufacturing Forecast by Region (2025-2030)
10.5.1 Egypt Market Biotechnology Contract Manufacturing Forecast
10.5.2 South Africa Market Biotechnology Contract Manufacturing Forecast
10.5.3 Israel Market Biotechnology Contract Manufacturing Forecast
10.5.4 Turkey Market Biotechnology Contract Manufacturing Forecast
10.6 Global Biotechnology Contract Manufacturing Forecast by Type (2025-2030)
10.7 Global Biotechnology Contract Manufacturing Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Biotechnology Contract Manufacturing Forecast
11 Key Players Analysis
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Biotechnology Contract Manufacturing Product Offered
11.1.3 Lonza Biotechnology Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Lonza Main Business Overview
11.1.5 Lonza Latest Developments
11.2 Thermo Fisher Scientific, Inc.
11.2.1 Thermo Fisher Scientific, Inc. Company Information
11.2.2 Thermo Fisher Scientific, Inc. Biotechnology Contract Manufacturing Product Offered
11.2.3 Thermo Fisher Scientific, Inc. Biotechnology Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Thermo Fisher Scientific, Inc. Main Business Overview
11.2.5 Thermo Fisher Scientific, Inc. Latest Developments
11.3 Catalent, Inc.
11.3.1 Catalent, Inc. Company Information
11.3.2 Catalent, Inc. Biotechnology Contract Manufacturing Product Offered
11.3.3 Catalent, Inc. Biotechnology Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Catalent, Inc. Main Business Overview
11.3.5 Catalent, Inc. Latest Developments
11.4 Samsung Biologics
11.4.1 Samsung Biologics Company Information
11.4.2 Samsung Biologics Biotechnology Contract Manufacturing Product Offered
11.4.3 Samsung Biologics Biotechnology Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Samsung Biologics Main Business Overview
11.4.5 Samsung Biologics Latest Developments
11.5 WuXi Biologics
11.5.1 WuXi Biologics Company Information
11.5.2 WuXi Biologics Biotechnology Contract Manufacturing Product Offered
11.5.3 WuXi Biologics Biotechnology Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 WuXi Biologics Main Business Overview
11.5.5 WuXi Biologics Latest Developments
11.6 Boehringer Ingelheim International GmbH
11.6.1 Boehringer Ingelheim International GmbH Company Information
11.6.2 Boehringer Ingelheim International GmbH Biotechnology Contract Manufacturing Product Offered
11.6.3 Boehringer Ingelheim International GmbH Biotechnology Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Boehringer Ingelheim International GmbH Main Business Overview
11.6.5 Boehringer Ingelheim International GmbH Latest Developments
11.7 FUJIFILM Holding Corporation
11.7.1 FUJIFILM Holding Corporation Company Information
11.7.2 FUJIFILM Holding Corporation Biotechnology Contract Manufacturing Product Offered
11.7.3 FUJIFILM Holding Corporation Biotechnology Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 FUJIFILM Holding Corporation Main Business Overview
11.7.5 FUJIFILM Holding Corporation Latest Developments
11.8 AbbVie, Inc.
11.8.1 AbbVie, Inc. Company Information
11.8.2 AbbVie, Inc. Biotechnology Contract Manufacturing Product Offered
11.8.3 AbbVie, Inc. Biotechnology Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 AbbVie, Inc. Main Business Overview
11.8.5 AbbVie, Inc. Latest Developments
11.9 Eurofins Scientific
11.9.1 Eurofins Scientific Company Information
11.9.2 Eurofins Scientific Biotechnology Contract Manufacturing Product Offered
11.9.3 Eurofins Scientific Biotechnology Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Eurofins Scientific Main Business Overview
11.9.5 Eurofins Scientific Latest Developments
11.10 AGC, Inc.
11.10.1 AGC, Inc. Company Information
11.10.2 AGC, Inc. Biotechnology Contract Manufacturing Product Offered
11.10.3 AGC, Inc. Biotechnology Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 AGC, Inc. Main Business Overview
11.10.5 AGC, Inc. Latest Developments
11.11 Merck KgaA
11.11.1 Merck KgaA Company Information
11.11.2 Merck KgaA Biotechnology Contract Manufacturing Product Offered
11.11.3 Merck KgaA Biotechnology Contract Manufacturing Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Merck KgaA Main Business Overview
11.11.5 Merck KgaA Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂